Royalty Pharma plc 10-Q for FY2026 Q3
Royalty Pharma plc (RPRX)
10-Q
2026-11-04
For: 2026-09-30
View Original
Added on
November 04, 2026
About this 10-Q
Royalty Pharma plc filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Royalty Pharma plc reported first-nine-month income from financial royalty assets of $1,880,627 thousand in 2026, up 12.7%, as net income attributable to the company fell 17.7% to $457,248 thousand. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $690.1M
- up 13.3% from $609.29M a year earlier
- Net income
- $144.68M
- down 49.1% from net income of $284.22M a year earlier
- Diluted EPS
- $0.32
- down 51.5% from $0.66 a year earlier